Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 408Rectal Neoplasms 152Colonic Neoplasms 150Pancreatic Neoplasms 114Stomach Neoplasms 110Neoplasm Metastasis 70Esophageal Neoplasms 60Esophageal Squamous Cell Carcinoma 33Neoplasms 31Adenocarcinoma Of Esophagus 27Gastrointestinal Neoplasms 17Cholangiocarcinoma 14Biliary Tract Neoplasms 14Gallbladder Neoplasms 12Carcinoma, Hepatocellular 12Adenocarcinoma 12Colorectal Cancer Metastatic 11Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 11Liver Neoplasms 10Digestive System Neoplasms 10Ovarian Neoplasms 9Small Cell Lung Carcinoma 8Locally Advanced Rectal Cancer 8Intestinal Neoplasms 8Bile Duct Neoplasms 8Carcinoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Digestive System Diseases 6Appendiceal Neoplasms 6

Interventions

asciminib 1Paclitaxel 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
P1b: Advanced Solid Tumors × Irinotecan × Gastrointestinal × Clear all
NCT04492033 2025-01-27

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Handok Inc.

Phase 1/2 Terminated
41 enrolled
GastrointestinalOther solid neoplasm

P1b: Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡